TLR4 signaling cascade, recruited and interacted with Myd88 that resulted in the MAPK and NF-κB activation upon LPS administration, has been reported to be highly associated with the response of neuroinflammation and involved in the development of AD and other Neurodegenerative disorder (26). Here, TLR4 is linked to Alzheimer disease.